Non disponible en dehors du Royaume-Uni et de l'Irlande
Analysis Note
To view the Certificate of Analysis for this product, please visit www.cytiva.com.
Application
The increased capacity of the medium is well suited for purification of Mabs from high-level expression feedstock.
Features and Benefits
Increased dynamic binding capacity with smaller particle size and greater porosity than MabSelect™ medium. MabSelect™ Xtra uses the same recombinant Protein A ligand as MabSelect™ Oriented coupling of recombinant Protein A to the matrix via an engineered C-terminal cysteine enhances IgG binding capacity. Fewer regulatory concerns due to the total absence of mammalian culture in the ligand production and purification. Prepacked HiTrap® columns for process development, screening of purification conditions, and small-scale purification of Mabs.
General description
HiTrap® MabSelect™ Xtra columns are prepacked with MabSelect™ Xtra, a BioProcess medium for capture of monoclonal antbodies from large sample volumes.
Legal Information
MabSelect is a trademark of Cytiva
HiTrap is a registered trademark of Cytiva
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :